Royalty Pharma plc (RPRX) insider trading

By person

15 insiders · 74 transactions

79.6×

Pablo Legorreta holds 79.6 times base salary in stock. $74.68M of shares against $937.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Pablo Legorreta last reported holding, valued at $57.10, the price Class A Ordinary Shares was last bought or sold at on the open market here, on 5 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Terrance P. Coyne

EVP & CFO

—

$38.96M (35) scheduled

−$38.96M

0.000%

$0.00

−100.0%

Christopher Hite

EVP & Chairman, Partnering

—

$27.36M (9) scheduled

−$27.36M

664,002

0.149%

$37.91M

−10.3%

George W. Lloyd

EVP, Investments & CLO

—

$13.81M (11) scheduled

−$13.81M

0.000%

$0.00

−100.0%

Marshall Urist

EVP, Research & Investments

—

$12.54M (18) scheduled

−$12.54M

19,020

0.004%

$1.09M

−71.0%

Gregory Norden

Director

—

$161.39K (1) scheduled

−$161.39K

196,348

0.044%

$11.21M

+158.1%

Pablo G. Legorreta

CEO, Chairman of the Board

—

1,307,820

0.294%

$74.68M

+1,950%

Errol B Desouza

Director

—

81,352

0.018%

$4.65M

+10.3%

Bonnie L Bassler

Director

—

79,823

0.018%

$4.56M

+33.5%

Henry A Fernandez

Director

—

65,324

0.015%

$3.73M

+21.0%

Ted W Love

Director

—

58,393

0.013%

$3.33M

+26.3%

Catherine M. Engelbert

Director

—

55,673

0.013%

$3.18M

+27.9%

David C Hodgson

Director

—

37,873

0.009%

$2.16M

+47.3%

Vlad Coric

Director

—

15,343

0.003%

$876.09K

—

Elizabeth H Weatherman

Director

—

13,103

0.003%

$748.18K

—

Carole Ho

Director

—

4,545

0.001%

$259.52K

—

Royalty Pharma plc

What the insiders did Scheduled selling only

By person